References

  1. Ravdin PM. Hormone replacement therapy and the increase in the incidence of invasive lobular cancer. Breast disease. 2008-2009;30:3-8. PubMed | Google Scholar

  2. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289(11):1421-4. PubMed | Google Scholar

  3. Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US and MR imaging findings. Radiographics. 2009;29(1):165-76. PubMed | Google Scholar

  4. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9):1046-52. PubMed | Google Scholar

  5. Reeves GK, Beral V, Green J, Gathani T, Bull D. Million Women Study Collaborators: Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol. 2006;7(11):910-8. Google Scholar

  6. Newcomer LM, Newcomb PA, Trentham-Dietz A, Longnecker MP, Greenberg ER. Oral contraceptive use and risk of breast cancer by histologic type. Int J Cancer. 2003;106(6):961-4. PubMed | Google Scholar

  7. Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomark. 2012;21(1):134-47. PubMed | Google Scholar

  8. Corso G, Intra M, Trentin C, Veronesi P, Galimberti V. CDH germline mutations and hereditary lobular breast cancer. Fam Cancer. 2016;15(2):215-9. PubMed | Google Scholar

  9. El Alouani C, Khouchani M, Omrani A, Benhmidoune A, Tahri A. Caractéristiques clinicopathologiques, thérapeutiques ET évolutives du cancer lobulaire du sein dans la région de Marrakech. Cancer/Radiothérapie. 2010;14(6-7):639.

  10. Wasif N, Maggard MA, Ko CY, Giuliano AE. Invasive lobular vs ductal breast cancer: a stage-matched comparison of outcomes. Ann surg oncol.2010;17(7):1862-19. PubMed | Google Scholar

  11. Porter AJ, Evans EB, Foxcroft LM, Simpson PT, Lakhani SR. Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imaging Radiat Oncol. 2014;58(1):1-10. PubMed

  12. Butler RS, Venta LA, Wiley EL, Ellis RL, Dempsey PJ, Rubin E. Sonographic evaluation of infiltrating lobular carcinoma. Am J Roentgenol. 1999;172(2):325-30. PubMed | Google Scholar

  13. Selinko VL, Middleton LP, Dempsey PJ. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 2004;32(7):323-32. PubMed | Google Scholar

  14. Suissa M, Lévy L, Tranbaloc P, Chiche JF, Martin B, Skaane P et al. Imagerie des cancers lobulaires infiltrants. Imag Femme. 2005;15:129-39. Google Scholar

  15. Balu-Maestro C, Chapellier C, Darcourt J, Ettore F, Raoust I. Imagerie dans le bilan d'extension ganglionnaire et métastatique du cancer du sein. J radiol (Paris). 2005 Nov;86(11):1649-57. PubMed | Google Scholar

  16. Chan A, Pintilie M, Vallis K, Girourd C, Goss P. Breast cancer in women ≤35 years: review of 1002 cases from a single institution. Ann Oncol. 2000;11(10):1255 -62. PubMed | Google Scholar

  17. Fondriner E, Guérin O, Lorimier G. Etude comparative de l'évolution métastatique des carcinomes canalaires et lobulaires du sein à partir de deux séries appariées (376 patientes). Bull cancer. 1997;84(12):1101-7. Google Scholar

  18. Diepenmaat LA, Sangen MJC, Poll-Franse LV. The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer. Radiother Oncol. 2009; 91(1):49-53. PubMed | Google Scholar

  19. Yu J, Bhargava R, Dabbs DJ. Invasive lobular carcinoma with extracellular mucin production and HER-2 over expression: a case report and further case studies. Diagn Pathol. 2010;5:36. PubMed | Google Scholar

  20. Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jone C, Mackay A et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. ClinCancer Res. 2006;12(22):6652-62. PubMed | Google Scholar